# DICYCLOMINE HYDROCHLORIDE
> **ANDA216760** · Abbreviated New Drug Application (Generic) · Sponsor: COREPHARMA · Approved 2022-11-28
## Drug
- **FDA Application Number:** ANDA216760
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DICYCLOMINE HYDROCHLORIDE
- **Generic name:** DICYCLOMINE HYDROCHLORIDE
- **Active ingredients:** DICYCLOMINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** COREPHARMA
- **Manufacturer:** Solaris Pharma Corporation
- **First approval:** 2022-11-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216760)
---
*MORVS · CC0 1.0*